These data indicate that the PI3K pathway plays a central role in driving the invasion of normal epithelial cells with reduced CTCF levels, while late-stage triple-negative breast cancer (TNBC) lines such as MDA-MB-231 may utilize multiple, or alternative, pathways to achieve this phenotype. Here, CTCF is linked to triple-negative breast carcinoma.